Previous close | 227.56 |
Open | 228.31 |
Bid | 224.19 x 1100 |
Ask | 233.96 x 800 |
Day's range | 227.02 - 234.66 |
52-week range | 195.47 - 254.00 |
Volume | |
Avg. volume | 510,317 |
Market cap | 23.012B |
Beta (5Y monthly) | 0.83 |
PE ratio (TTM) | 41.94 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.08 (0.91%) |
Ex-dividend date | 12 Jun 2024 |
1y target est | N/A |
Key Insights STERIS to hold its Annual General Meeting on 1st of August Salary of US$1.03m is part of CEO Dan...
STERIS' (STE) first-quarter fiscal 2025 results are likely to reflect the positives of the normalization of the Healthcare backlog, along with a core focus on pharma and MedTech.
Key Insights The projected fair value for STERIS is US$320 based on 2 Stage Free Cash Flow to Equity Current share...